Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 4/20 | 0.48 |
| ▸ | CLK4 | Q9HAZ1 | 4/20 | 0.48 |
| ▸ | CLK1 | P49759 | 3/20 | 0.48 |
| ▸ | DYRK1B | Q9Y463 | 3/20 | 0.47 |
| ▸ | MKNK1 | Q9BUB5 | 3/20 | 0.47 |
| ▸ | ROCK2 | O75116 | 5/20 | 0.44 |
| ▸ | ROCK1 | Q13464 | 4/20 | 0.44 |
| ▸ | CLK2 | P49760 | 2/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | NCOR1 | O75376 | 1/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.42 |
| ▸ | ACP1 | P24666 | 1/20 | 0.41 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.40 |
| ▸ | RAF1 | P04049 | 1/20 | 0.40 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.40 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.40 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.40 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.40 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2179774 | 0.92 | CLK4 (0.50) | DYRK1ACLK4CLK1DYRK1BMKNK1 | |
| SCHEMBL2176199 | 0.92 | MITF (0.47) | DYRK1ACLK4CLK1DYRK1BMKNK1 | |
| SCHEMBL2177386 | 0.91 | HDAC3 (0.49) | DYRK1ACLK4CLK1DYRK1BMKNK1 | |
| SCHEMBL2178193 | 0.90 | DYRK1A (0.47) | DYRK1ACLK4CLK1DYRK1BMKNK1 | |
| SCHEMBL2177434 | 0.88 | VNN1 (0.42) | DYRK1ACLK4CLK1DYRK1BMKNK1 | |
| SCHEMBL2178911 | 0.87 | CASR (0.39) | DYRK1ACLK4CLK1DYRK1BMKNK1 | |
| SCHEMBL2178583 | 0.87 | CCNT1 (0.45) | DYRK1ACLK4CLK1DYRK1BMKNK1 | |
| SCHEMBL2176860 | 0.86 | HDAC3 (0.38) | DYRK1ACLK4CLK1DYRK1BMKNK1 | |
| SCHEMBL2180425 | 0.86 | HDAC3 (0.44) | DYRK1ACLK4CLK1DYRK1BMKNK1 | |
| SCHEMBL2178733 | 0.86 | MKNK1 (0.48) | DYRK1ACLK4CLK1DYRK1BMKNK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110166137-A1 | Substituted Naphthalenyl-Pyrimidine Compounds | ARQULE, INC. (US) | 2011-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166137-A1 | Substituted Naphthalenyl-Pyrimidine Compounds | DPYD, TP53, TYMP | DYRK1A 2574/4885CLK4 3301/4885CLK1 3413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.